(Q42232134)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Luiz F Lisboa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Khaled Barakat

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

11

Michael Houghton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

3

Deanna M Santer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Adrian Egli

1

object named as

Adrian Egli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Daire O'Shea

5

object named as

Daire O'Shea

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rakesh Bhat

9

object named as

Rakesh Bhat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Aviad Levin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Michael Joyce

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Karl P Fischer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

D Lorne Tyrrell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Deepali Kumar

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Atul Humar

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

language of work or name

English

0 references

publication date

11 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

Journal of Infectious Diseases

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

717-727

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24620020%20AND%20SRC:MED&resulttype=core&format=json

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Interferon lambdas: the next cytokine storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Interferon-inducible antiviral effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Genetic variation of the IL-28B promoter affecting gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Viral strategies of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Interferon- Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

CD40 Stimulation of Human Peripheral B Lymphocytes: Distinct Response from Naive and Memory Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Recognition of herpesviruses by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU144